Sign in

MedPage Today

@medpagetoday.com
2.4K followers 353 following 4.4K posts

Better informed, better care. #MedPageToday Reposts, likes, and comments are not endorsements.

PostsRepliesMedia
MedPage Today @medpagetoday.com · 1h
"We have direct evidence that the farm-to-clinic pathway is not theoretical, and that closing it works." Read the #OpEd from Hana Kahleova, MD, PhD, director of clinical research at the Physicians Committee for Responsible Medicine, at: www.medpagetoday.com/opinion/second…
medpagetoday.com
Opinion | We Keep Treating Resistant Infections. We Rarely Ask Where the Resistance Came From.
The farm-to-clinic pathway is not theoretical
010
MedPage Today @medpagetoday.com · 6h
Maternal health conditions during pregnancy were consistently associated with autism spectrum disorder but several factors varied across race and ethnic groups, a large retrospective study of U.S. children showed. Read more at: www.medpagetoday.com/neurology/auti…
medpagetoday.com
Autism Linked to Maternal Health Factors
Four conditions in white mothers had stronger associations with autism
000
MedPage Today @medpagetoday.com · 23h
The FDA on Friday expanded the approval of pirtobrutinib (Jaypirca) in chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) to include the first-line treatment of adults whose cancers have no known 17p deletion. www.medpagetoday.com/hematologyonco…
medpagetoday.com
Non-Covalent BTK Drug Wins Broad Approval in Most Common Leukemia
Pirtobrutinib now approved for CLL/SLL in frontline setting
000
MedPage Today @medpagetoday.com · 05/10/2026
Unannounced drills that used professional actors posing as patients exposed some gaps in how healthcare facilities respond to a potential infectious disease outbreak, according to a study of three jurisdictions. Read more at: www.medpagetoday.com/infectiousdise…
000
MedPage Today @medpagetoday.com · 05/10/2026
The investigational triple agonist retatrutide substantially improved glycemic control and body weight in adults with obesity and type 2 diabetes, a phase III trial showed. Read more at: www.medpagetoday.com/meetingcoverag…
medpagetoday.com
Retatrutide Delivers Substantial Weight Loss in Type 2 Diabetes
3-11% dropped out because of adverse events
000
MedPage Today @medpagetoday.com · 05/10/2026
Higher medical debt burden was associated with a higher incidence of late-stage cancer diagnoses, according to a cross-sectional study of U.S. counties. Read more at: www.medpagetoday.com/hematologyonco…
medpagetoday.com
More Medical Debt Linked to More Deadly Cancers
Patterns in overall cancer incidence were similar
010
MedPage Today @medpagetoday.com · 05/10/2026
Starting a GLP-1 receptor agonist after giving birth is becoming more common, an analysis of claims data showed. @sihtingcai.bsky.social www.medpagetoday.com/obgyn/pregnanc…
medpagetoday.com
More New Moms Are Starting GLP-1 Drugs
Evidence regarding safety in this population hasn't kept pace, researchers warn
010
MedPage Today @medpagetoday.com · 04/10/2026
Over 2 million new cancer cases were attributable to infections globally in 2024, according to an analysis of worldwide cancer incidence, highlighting the importance of effective prevention measures. Read more at: www.medpagetoday.com/infectiousdise…
medpagetoday.com
Millions of Cancers Linked to Infections, Study Says
Four of the five leading infectious causes have 'highly effective' prevention measures
021
MedPage Today @medpagetoday.com · 04/10/2026
Users of GLP-1 receptor agonists had as much as fourfold higher likelihood for nail disorders, particularly onycholysis, compared with patients not taking the drugs, a large prospective study showed. #EADVCongress www.medpagetoday.com/meetingcoverag…
medpagetoday.com
GLP-1s Tied to Detached Fingernails in New Study
Nail discoloration also an issue, and direct effect of drugs cannot be ruled out
010
MedPage Today @medpagetoday.com · 03/10/2026
"Payouts encourage future attacks and perpetuate the cycle. Still, when the patients you've given an oath to protect are at risk, how do you say no?" Read the #OpEd from urologist and reconstructive pelvic surgeon Elizabeth Dray, MD, at: www.medpagetoday.com/opinion/second…
medpagetoday.com
Opinion | Who Should Manage a Hospital Cyberattack?
Proper cyberattack response and deterrence requires government resources
001
MedPage Today @medpagetoday.com · 03/10/2026
If one tick bite seems bad enough, imagine a whole explosion of them latching onto an ankle or crawling up a leg at once. Read more at: www.medpagetoday.com/infectiousdise…
medpagetoday.com
What Is a 'Tick Bomb' and Does It Cause Disease?
'No one wants a tick bomb on their ankle,' says public health entomologist
030
MedPage Today @medpagetoday.com · 03/10/2026
Ultralow-dose radiation therapy provided durable pain relief from multiple myeloma bone metastases with few adverse effects and minimal impact on bone marrow status, a prospective clinical trial showed. www.medpagetoday.com/meetingcoverag…
medpagetoday.com
Ultralow-Dose RT Quells Bone Pain in Myeloma, Preserves Bone Marrow
Pain response rate of 86% at 6 months with low rates of adverse events, re-irradiation
085
MedPage Today @medpagetoday.com · 02/10/2026
The investigational triple agonist retatrutide substantially improved glycemic control and body weight in adults with obesity and type 2 diabetes, a phase III trial showed. www.medpagetoday.com/meetingcoverag…
medpagetoday.com
Retatrutide Delivers Substantial Weight Loss in Type 2 Diabetes
3-11% dropped out because of adverse events
000
MedPage Today @medpagetoday.com · 02/10/2026
"Fraternity culture is not merely a conduct issue. It is an unaddressed public health crisis." Read the #OpEd by Katie Quinn: www.medpagetoday.com/opinion/second…
medpagetoday.com
Opinion | Greek Life's Darkest Secret Isn’t Just Violence. It's Biohazards.
Frat culture must be treated as an environmental and communicable health hazard
001
MedPage Today @medpagetoday.com · 02/10/2026
Physician groups are pushing back against recent remarks by HHS Secretary Robert F. Kennedy Jr. suggesting that artificial intelligence (AI) can be superior to physicians for making diagnoses and prescribing drugs. www.medpagetoday.com/practicemanage…
medpagetoday.com
Doctors Push Back on RFK Jr.'s AI Comments
Suggesting AI is better informed than doctors risks undermining patient trust, they say
031
MedPage Today @medpagetoday.com · 02/10/2026
Hypofractionated postmastectomy radiotherapy continued to provide locoregional control for patients with high-risk breast cancer, 10-year data from a phase III trial showed. @astro-org.bsky.social #ASTRO26 www.medpagetoday.com/meetingcoverag…
medpagetoday.com
More Evidence for Shorter Radiation Regimen in High-Risk Breast Cancer
Durable disease control at 10 years with hypofractionated postmastectomy radiotherapy
000
MedPage Today @medpagetoday.com · 02/10/2026
Adults with type 2 diabetes achieved impressive weight loss with an investigational combination agent of eloralintide plus tirzepatide (Mounjaro, Zepbound), according to a phase IIb study. @easdnews.bsky.social #EASD2026 www.medpagetoday.com/meetingcoverag…
medpagetoday.com
Striking Weight Loss Seen With Combo Drug in Diabetes Trial
But more than one in four study participants quit trial due to adverse events
010
MedPage Today @medpagetoday.com · 02/10/2026
The FDA approved the Autus Size-Adjustable Valve for surgical pulmonary valve replacement in children with congenital heart disease, the agency announced on Thursday. www.medpagetoday.com/cardiology/gen…
medpagetoday.com
FDA Approves Only Surgical Pulmonary Valve Fit for Growing Kids
The valve is designed to be expanded over time, which could reduce the need for repeat surgeries
000
MedPage Today @medpagetoday.com · 02/10/2026
An investigational dual GIP/GLP-1 agonist achieved modest weight loss in adults with type 2 diabetes and obesity, the phase III SYNCHRONIZE-2 trial showed, but tolerability remains a concern. @easdnews.bsky.social #EASD2026 www.medpagetoday.com/meetingcoverag…
medpagetoday.com
Novel GIP/GLP-1 Yields Uneven Findings in Diabetes Patients With Obesity
Phase III trial of survodutide showed modest weight loss and high discontinuation rates
021
MedPage Today @medpagetoday.com · 02/10/2026
Use of GLP-1 receptor agonists around pregnancy did not appear to increase adverse maternal or perinatal outcomes, according to two studies. Read more at: www.medpagetoday.com/meetingcoverag…
medpagetoday.com
No Clear Risks With GLP-1s Around Pregnancy, but Caution Urged
Contraception during use is still recommended, researcher says
011
MedPage Today @medpagetoday.com · 01/10/2026
Cemdisiran, an investigational siRNA therapeutic targeting complement component 5, led to fewer hospitalized myasthenia gravis patients compared with placebo, a prespecified exploratory analysis of NIMBLE trial data showed. www.medpagetoday.com/meetingcoverag…
medpagetoday.com
Cemdisiran Linked With Fewer Hospitalizations in Myasthenia Gravis Study
Exploratory analysis ties siRNA therapeutic with fewer myasthenic crises
000
MedPage Today @medpagetoday.com · 01/10/2026
The FDA expanded its approval of mavacamten (Camzyos) to include children with symptomatic obstructive hypertrophic cardiomyopathy. www.medpagetoday.com/cardiology/gen…
medpagetoday.com
Drug Approval for Painful Heart Condition Expands to Kids
Camzyos is the first cardiac myosin inhibitor approved for pediatric symptomatic obstructive HCM
000
MedPage Today @medpagetoday.com · 01/10/2026
While rare, sepsis in pregnancy was nevertheless involved in nearly a third of maternal deaths in Mississippi, a state with one of the highest maternal mortality rates, and women with certain characteristics were particularly vulnerable. www.medpagetoday.com/criticalcare/s…
medpagetoday.com
Sepsis in Pregnancy Is a Deadly Combo: Here's Who's at Risk
In maternal mortality hotspot, 32% of delivery-associated hospital deaths involved sepsis
001
MedPage Today @medpagetoday.com · 01/10/2026
Intravenous efgartigimod (Vyvgart) continued to demonstrate efficacy and safety in patients with generalized myasthenia gravis who did not have detectable AChR antibodies, data from the open-label period of the ADAPT SERON trial showed. www.medpagetoday.com/meetingcoverag…
medpagetoday.com
Efgartigimod Shows Sustained Efficacy in Myasthenia Gravis Subtypes
Benefits continued for patients without antibodies to the acetylcholine receptor
000
MedPage Today @medpagetoday.com · 01/10/2026
Orforglipron (Foundayo) was able to claim cardiovascular safety based on the ACHIEVE-4 trial, though heart benefits remain unproven. @easdnews.bsky.social #EASD2026 www.medpagetoday.com/meetingcoverag…
medpagetoday.com
New Easier-to-Use GLP-1 Pill Safe for the Heart, Study Says
Orforglipron met expectations in ACHIEVE-4, with cardiovascular benefit yet to be proven
010
MedPage Today @medpagetoday.com · 01/10/2026
While patients with lean MASLD have less severe histologic disease, they still had a similar risk of adverse clinical outcomes as those with overweight/obese MASLD, according to a multinational retrospective study. www.medpagetoday.com/gastroenterolo…
medpagetoday.com
'Lean' MASLD May Sound Better, but Study Suggests Otherwise
These patients had a similar risk of adverse outcomes as those with overweight/obese MASLD
000
MedPage Today @medpagetoday.com · 01/10/2026
Most physician specialties had an increase in average starting salary from last year, according to AMN Healthcare's 2026 report on recruiting incentives. Read more at: www.medpagetoday.com/publichealthpo…
medpagetoday.com
These Specialties Had the Highest Starting Salaries This Year
The average starting salary for physicians is $419,000, with signing bonuses for the majority
000
MedPage Today @medpagetoday.com · 01/10/2026
An all-oral treatment regimen for advanced ER-positive breast cancer almost doubled PFS versus standard endocrine therapy in a study of post-CDK4/6 progression disease. @elmayermd.bsky.social www.medpagetoday.com/hematologyonco…
medpagetoday.com
SERD Combination Slows Breast Cancer After CDK4/6 Inhibitor Progression
PFS twice as long in ESR1-mutated subgroup with giredestrant and everolimus
021
MedPage Today @medpagetoday.com · 01/10/2026
Robotically assisted knee and hip arthroplasties have brought no extra benefits for patients in Great Britain compared with conventional procedures, a massive review of registry data showed. www.medpagetoday.com/surgery/orthop…
medpagetoday.com
Epic Fail: Robots Don't Improve Joint Replacement Outcomes in Big U.K. Studies
Could sink British plan to ramp up robotic arthroplasties
000
MedPage Today @medpagetoday.com · 01/10/2026
Leadership of the agency that oversees the U.S. Preventive Services Task Force (USPSTF) suppressed the group's recommendations, a former task force chair said. Read more at: www.medpagetoday.com/washington-wat…
medpagetoday.com
Trump Administration Suppressed USPSTF Recommendations, Past Chair Says
Group's recommendations on cervical cancer screening, cardiovascular prevention were blocked
000
MedPage Today @medpagetoday.com · 30/09/2026
Proton therapy failed to improve survival in locally advanced HCC compared with photons, surprising investigators in the multicenter randomized NRG-GI003 trial. @astro-org.bsky.social #ASTRO25 www.medpagetoday.com/meetingcoverag…
medpagetoday.com
Unexpected Lack of Survival Benefit in Liver Cancer Treated With Proton Therapy
Overall survival twice as high after photon radiotherapy, no difference in PFS, local progression
000
MedPage Today @medpagetoday.com · 30/09/2026
Physicians at Allina Health reached a tentative agreement following a 4-day strike on their first union contract, which still awaits ratification. Saul Singh, DO, described why he believes physicians need a greater voice in how healthcare is delivered. www.medpagetoday.com/hospitalbase...
000
MedPage Today @medpagetoday.com · 30/09/2026
A hearing aid intervention did not reduce dementia incidence among people with mild cognitive impairment and hearing loss in the CHOICE trial, but a secondary outcome suggested that it may have increased the rate of cognitive improvement. www.medpagetoday.com/neurology/deme…
medpagetoday.com
Unexpected Cognitive Improvement Emerges in Hearing Aid Trial
Treating hearing loss may help some people regain cognitive and functional capacity, data suggest
031
MedPage Today @medpagetoday.com · 30/09/2026
Should Medicare's annual wellness visit (AWV) be less physician-driven and more artificial intelligence (AI)-driven? That's the question being asked by CMS in its proposed physician payment rule, issued this past summer. Read more at: www.medpagetoday.com/publichealthpo…
medpagetoday.com
Is AI Coming to the Medicare Annual Wellness Visit?
CMS asks whether AI should be used to collect patient data before visits and help with follow-up
100
MedPage Today @medpagetoday.com · 30/09/2026
Mivocabtagene autoleucel, an autologous CD19 CAR-T cell therapy, showed benefits lasting 6 months or longer for generalized myasthenia gravis patients in the phase II portion of the KYSA-6 trial. #AANEM www.medpagetoday.com/meetingcoverag…
medpagetoday.com
CAR-T Therapy Shows Durable Benefits in Myasthenia Gravis
Miv-cel sustains improvements at 24 weeks
010
MedPage Today @medpagetoday.com · 30/09/2026
"She can oversee meaningful reforms while remaining a loyal advocate for the science, process, and staff that are the agency's DNA." Read the #OpEd from policy analyst and regulatory expert Steven Grossman, JD, at: www.medpagetoday.com/opinion/second…
medpagetoday.com
Opinion | Leading FDA Is an Impossible Job Right Now. Heidi Overton Could Still Do It Well.
My support rests on her recognition that the agency is bound by law, science, and process
000
MedPage Today @medpagetoday.com · 30/09/2026
Local control after surgical removal of large brain metastases improved significantly when patients received fractionated SRS instead of single-fraction SRS, a randomized trial showed. #ASTRO26 @astro-org.bsky.social www.medpagetoday.com/meetingcoverag…
medpagetoday.com
Fractionated SRS Improves Local Control After Brain Metastasis Resection
Surgical-bed control, OS, freedom from whole-brain RT favor fractionated over single-fraction SRS
001
MedPage Today @medpagetoday.com · 30/09/2026
What if writing and submitting an academic paper didn't take weeks or months, but instead could be done over the course of just one weekend at a premium hotel with plenty of snack breaks? Read more at: www.medpagetoday.com/special-report…
medpagetoday.com
Boot Camp Promises a Submitted Paper in Just 2 Days
Critics worry AI-aided program enables shoddy research
000
MedPage Today @medpagetoday.com · 29/09/2026
Commercial insurance formularies have posed a barrier to cutting greenhouse gas emissions from metered-dose inhalers used to treat asthma and chronic obstructive pulmonary disease (COPD), a study showed. Read more at: www.medpagetoday.com/pulmonology/as…
medpagetoday.com
Insurance Formularies Holding Up Lower-Emission Asthma, COPD Inhalers
Options that reduce greenhouse gases face lower rates of coverage and more administrative hurdles
031
MedPage Today @medpagetoday.com · 29/09/2026
In an #OpEd for MedPage Today, Alex Smolak, PhD, an epidemiologist with the Infectious Disease Epidemiology Group at Weill Cornell Medicine-Qatar, responds to the $17.1 billion Meta settlement and points to a "natural experiment." www.medpagetoday.com/opinion/seco...
000
MedPage Today @medpagetoday.com · 29/09/2026
The FDA approved tiratricol (Emcitate) to treat peripheral thyrotoxicosis in patients with monocarboxylate transporter 8 deficiency, the agency announced on Monday, marking the first approval for this rare genetic disorder. www.medpagetoday.com/endocrinology/…
medpagetoday.com
FDA Approves First Treatment for Rare Thyroid Hormone Disorder
Tiratricol is indicated for patients with MCT8 deficiency
000
MedPage Today @medpagetoday.com · 29/09/2026
Identical twin physicians who returned to their hometown of Richmond, Virginia, to co-lead the emergency department at a local hospital have been garnering recent media attention. Read more at: www.medpagetoday.com/emergencymedic…
medpagetoday.com
Twin Doctors Lead Hometown Emergency Department
The Jaspers overcame difficult circumstances to give back to their community
010
MedPage Today @medpagetoday.com · 29/09/2026
Fasting less than 8 hours before routine blood tests generally did not change results, with few exceptions, according to an observational study. Read more at: www.medpagetoday.com/primarycare/pr…
medpagetoday.com
Few Lab Tests Actually Need 8 Hours of Fasting, Study Suggests
Findings support a step away from routine fasting, but glucose is one exception
152
MedPage Today @medpagetoday.com · 29/09/2026
Young adult patients with persistent knee pain following ACL repair surgery got more relief from a supervised physical therapy program compared with self-directed rehab, results of a randomized trial indicated. @jbdriban.bsky.social www.medpagetoday.com/surgery/orthop…
medpagetoday.com
Still in Pain After ACL Repair? Supervised Rehab Superior to Exercises Alone
Randomized trial answers longstanding clinical question
001
MedPage Today @medpagetoday.com · 28/09/2026
A 53-year-old woman with severe eye symptoms had already seen multiple specialists before finally being diagnosed with a rare condition that's more often seen in children and young adults. Read more at: www.medpagetoday.com/casestudies/op…
medpagetoday.com
She Developed a Rare Eye Disease After a Strep Infection
53-year-old woman is second-oldest patient reported to have post-streptococcal uveitis syndrome
010
MedPage Today @medpagetoday.com · 28/09/2026
Patients with community-onset presumed bacterial sepsis were less likely to get timely antibiotics if they had GI or respiratory symptoms at the time of presentation, an observational cohort study found. www.medpagetoday.com/criticalcare/s…
medpagetoday.com
Two Symptoms Linked to Antibiotic Delays in Presumed Sepsis
GI and respiratory symptoms at presentation both flagged in observational study
031
MedPage Today @medpagetoday.com · 28/09/2026
"The debate over anesthesia reimbursement is not merely a dispute among professionals. It is a question of fairness and access." Read the #OpEd from Mary Scott-Herring, DNP, MS, CRNA, at: www.medpagetoday.com/opinion/second…
medpagetoday.com
Opinion | It's Time for Reimbursement Parity in Anesthesia
Equal pay for equivalent services from CRNAs is essential to protecting timely access to care
000
MedPage Today @medpagetoday.com · 28/09/2026
The FDA approved the dopamine agonist tavapadon (Juvmo) to treat adults with Parkinson's disease, drugmaker AbbVie announced Monday. medpagetoday.com/neurology/parkinso…
medpagetoday.com
Parkinson's Disease Gets New Treatment Approved
FDA gives go-ahead to D1/D5 dopamine agonist tavapadon
062
MedPage Today @medpagetoday.com · 28/09/2026
The FDA expanded the indications for the B-cell depleter obinutuzumab (Gazyva) to include idiopathic nephrotic syndrome, the agency announced on Friday, the first new option for the rare kidney disease in more than half a century. www.medpagetoday.com/nephrology/gen…
medpagetoday.com
First New Drug Approved for Idiopathic Nephrotic Syndrome in 70 Years
Anti-CD20 agent obinutuzumab (Gazyva) gets green light for patients as young as 2 years
011
MedPage Today @medpagetoday.com · 28/09/2026
Support from the AMA to classify nearsightedness as a disease created momentum to increase access to evidence-based treatment and stave off a public health crisis, according to the nation's largest ophthalmology group. www.medpagetoday.com/ophthalmology/…
medpagetoday.com
Growing Support for Initiatives to Recognize Myopia as a Disease
Risk of vision-threatening complications of nearsightedness gets attention of AMA, Congress
011